ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company’s high standard of quality and safety

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality, and personalized for their needs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118954274/en/

Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company’s high standard of quality and safety. (Photo: Business Wire)

Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company’s high standard of quality and safety. (Photo: Business Wire)

Autor brings more than 30 years of experience across pharmaceutical quality and compliance, regulatory programs, and consumer protection to Hims & Hers. She previously served as the Deputy Commissioner for Global Regulatory Operations and Policy at the FDA, where she oversaw FDA inspections, criminal investigations, and international operations for the agency. She also served as the agency’s Director of the Office of Compliance for the Center for Drug Evaluation and Research, leading enforcement for drug requirements. As a trial attorney for the Department of Justice, the FDA was her primary client. She has also served as the Global Head of Regulatory Excellence at AstraZeneca and is currently the CEO of Healthcare Innovation Catalysts.

Stevens has spent her entire career in pharmaceutical quality assurance, operations, and engineering. She joins Hims & Hers from Hillrom, where she served as the Chief Quality Officer, helping the company achieve top-quartile results in global quality regulations. She also served as Pfizer’s Vice President of Sterile Injectable Quality Operations, where she led the company’s quality organizations and enabled successful regulatory inspections globally with regulatory authorities like the FDA, MHRA, and Health Canada.

“We’ve built a customer experience that prioritizes clinical excellence and the highest standard of safety and quality for every person who trusts us with their journey,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “The depth of expertise Deb and Janet bring to the team is incredibly valuable as we continue to scale our operations to meet the needs of the growing number of customers who come to our platform seeking healthcare solutions that fit their individual needs.”

“Affordable, accessible, convenient healthcare for US consumers is lacking, and Hims & Hers is addressing that need,” said Deb Autor. “In my many decades in the healthcare field, this is the first company I’ve seen achieving scale, impact, and quality while pushing innovation in the service of patients. This is an exciting moment and I’m thrilled to be part of it.”

“Customers put an immense amount of trust in healthcare companies, and Hims & Hers is one of the few companies doing the meaningful work to earn that trust,” said Janet Stevens. “The safety of our operations is the foundation of connection we have with our customers. Continuing to strengthen that connection will be a critical part of impacting more lives on our platform.”

Autor joins health and pharmaceutical industry experts on the Hims & Hers Board of Directors including: former Novo Nordisk executive, Kåre Schultz; former CEO of the Cleveland Clinic, Dr. Toby Cosgrove; US regulatory and foreign policy expert, Anja Manuel; and former Chief Medical Officer of Walgreens and current Chief Medical Officer of Hims & Hers, Patrick Carroll, amongst others.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.